Thomas M. Herndon

954 total citations
15 papers, 750 citations indexed

About

Thomas M. Herndon is a scholar working on Immunology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas M. Herndon has authored 15 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 3 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas M. Herndon's work include T-cell and B-cell Immunology (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). Thomas M. Herndon is often cited by papers focused on T-cell and B-cell Immunology (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). Thomas M. Herndon collaborates with scholars based in United States. Thomas M. Herndon's co-authors include Elena E. Solomou, George C. Tsokos, Keyvan Keyvanfar, Xingmin Feng, Jichun Chen, Neal S. Young, Sachiko Kajigaya, Peter J. Munson, Richard Pazdur and Nalini Raghavachari and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Thomas M. Herndon

13 papers receiving 737 citations

Peers

Countries citing papers authored by Thomas M. Herndon

Since Specialization

Citations

This map shows the geographic impact of Thomas M. Herndon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Herndon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Herndon more than expected).

Fields of papers citing papers by Thomas M. Herndon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Herndon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Herndon. The network helps show where Thomas M. Herndon may publish in the future.

Co-authorship network of co-authors of Thomas M. Herndon

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Herndon. A scholar is included among the top collaborators of Thomas M. Herndon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Herndon. Thomas M. Herndon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Safety outcomes when switching between biosimilars and reference biologics: A systematic review and meta-analysis 2023 ·PLoS ONE ·Thomas M. Herndon, Cristina Ausín, (unknown), Sarah J. Schrieber, Michelle Luo, (unknown), Carol H. Kim, Wanjie Sun, (unknown), Stella Grosser, (unknown), M. Ricci	25
2	Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood 2017 ·Leukemia ·Thomas M. Herndon, (unknown), Nakhle S. Saba, Janet Valdez, Claire Emson, Michelle Gatmaitan, Xin Tian, Thomas E. Hughes, Clare Sun, D Arthur, Maryalice Stetler‐Stevenson, Christina M. Yuan, Carsten Utoft Niemann, Gerald E. Marti, Georg Aue, S. Soto, Mohammed Farooqui, Sarah E. M. Herman, Nicholas Chiorazzi, Adrian Wiestner	88
3	Intraclonal Complexity Of CLL Fractions In Cell Proliferation Rates, Gene Expression Signatures, and Responses To Autologous T-Cell Help In Peripheral blood and Secondary Lymphoid Tissues 2013 ·Blood ·Shih‐Shih Chen, Thomas M. Herndon, Claire Emson, John C. Riches, Fabienne McClanahan, Timothy Tong, Xiao‐Jie Yan, Piers Patten, John G. Gribben, Adrian Wiestner, Nicholas Chiorazzi	1
4	U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma 2013 ·Clinical Cancer Research ·Thomas M. Herndon, Albert Deisseroth, Edvardas Kaminskas, Robert C. Kane, Kallappa M. Koti, Mark D. Rothmann, Bahru Habtemariam, Julie Bullock, Jeffrey D. Bray, Jessica J. Hawes, Todd R. Palmby, (unknown), William M. Adams, (unknown), Janice Brown, Angelica Dorantes, Rajeshwari Sridhara, Ann T. Farrell, Richard Pazdur	198
5	U.S. Food and Drug Administration Approval: Peginterferon-alfa-2b for the Adjuvant Treatment of Patients with Melanoma 2012 ·The Oncologist ·Thomas M. Herndon, Suzanne Demko, Xiaoping Jiang, Kun He, Joseph E. Gootenberg, Martin H. Cohen, Patricia Keegan, Richard Pazdur	67
6	Direct in Vivo Evidence of Increased Chronic Lymphocytic Leukemia Cell Proliferation in Lymph Nodes Compared to Bone Marrow and Peripheral Blood 2012 ·Blood ·Thomas M. Herndon, Shih‐Shih Chen, Michelle Gatmaitan, Claire Emson, Janet Valdez, Nakhle S. Saba, Nicholas Chiorazzi, Adrian Wiestner	1
7	Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro 2008 ·Blood ·Xingmin Feng, Sachiko Kajigaya, Elena E. Solomou, Keyvan Keyvanfar, (unknown), Nalini Raghavachari, Peter J. Munson, Thomas M. Herndon, Jichun Chen, Neal S. Young	191
8	Rabbit ATG but Not Horse ATG Promotes Expansion of Functional CD4+CD25highFoxP3 Regulatory T Cells In Vitro. 2007 ·Blood ·Xingmin Feng, Elena E. Solomou, Keyvan Keyvanfar, Thomas M. Herndon, Jichun Chen, Sachiko Kajigaya, Neal S. Young	4
9	Cold-Water Immersion in a 22-Year-Old Service Member 2006 ·Military Medicine ·(unknown), Thomas M. Herndon	5
10	T cell-to-T cell clustering enhances NF-κB activity by a PI3K signal mediated by Cbl-b and Rho 2005 ·Biochemical and Biophysical Research Communications ·Thomas M. Herndon, Dana M. Pirone, George C. Tsokos, Christopher S. Chen	8
11	Direct Transfer of p65 into T Lymphocytes from Systemic Lupus Erythematosus Patients Leads to Increased Levels of Interleukin-2 Promoter Activity 2002 ·Clinical Immunology ·Thomas M. Herndon, Yuang‐Taung Juang, Elena E. Solomou, Stephen W. Rothwell, Mark F. Gourley, George C. Tsokos	42
12	Alveolar Hemorrhage and Pulmonary Hypertension in Systemic Sclerosis: A Continuum of Scleroderma Renal Crisis? 2001 ·JCR Journal of Clinical Rheumatology ·Thomas M. Herndon, (unknown), (unknown), Lisa K. Moores, Robert J. Oglesby, G. Dennis	3
13	ZAP-70 and SLP-76 Regulate Protein Kinase C-θ and NF-κB Activation in Response to Engagement of CD3 and CD28 2001 ·The Journal of Immunology ·Thomas M. Herndon, Xiaochuan Shan, George C. Tsokos, Ronald L. Wange	65
14	Effects of prolactin on chloride cells in opercular membrane of seawater-adapted tilapia 1991 ·General and Comparative Endocrinology ·Thomas M. Herndon, Stephen D. McCormick, Howard A. Bern	51
15	American Manuscript Collections of Medieval Medical Miniatures and Texts 1962 ·Journal of the History of Medicine and Allied Sciences ·Loren C. MacKinney, Thomas M. Herndon	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact